Key result
Vaccination with 100 μg and 150 μg of recombinant VP1 protein induced protective neutralizing antibody titers (>1.2) in guinea pigs compared to negative control (P<0.05).
Absolute Event Rate: 1.95% vs 0.6%
p-value: p=<0.05
Recombinant VP1 protein of FMD virus type O/IRN/2010 can be successfully expressed and induces protective neutralizing antisera in animal models.
Background and Aims: Foot and Mouth Disease (FMD) is a highly contagious disease among cloven-hoofed animals. FMD virus has structural and non-structural proteins. Vp1 is the most immunogenic structural peptides of FMD virus, applied for major vaccine studies. The aim of this study was construction of Pet28-VP1 cassette for FMD virus type O/IRN/2010 and expression VP1 peptide as the most immunogenic antigen was the aim of this study. Materials and Methods: FMD virus type O/IRN/2010 was isolated from cattle in Qom, Iran and propagated on IBRS 2 and BHK 21 cell lines. The VP1 gene was amplified using the specific primer pair and RT-PCR technique. The purified PCR product was sub-cloned into the unique BamHI and Xho1 cloning sites to construct the PTZ57R/T -VP1 cassette. The DH 5 strain was transformed with this cassette. The digested VP1 gene was cloned in the digested Pet28 and confirmed using double digestion. Then the Pet28-VP1 construction was transformed in BL21 strain. Results: Expression of VP1 peptide was evaluated by IPTG induction and SDS-PAGE and confirmed using Guinea pig specific polyclonal antibody against FMD virus type O and conjugated rabbit anti Guinea pig antibody-HRP. Also neutralizing antisera titre was protective for vaccinated animals by recombinant VP1 protein.
No takes yet. Share an insight, caveat, or question.
Motamedi-Sedeh et al. (2014) studied Foot and Mouth Disease (FMD) (n=12). Recombinant VP1 protein of FMD virus type O/IRN/2010 vs. Negative control was evaluated on Neutralizing antibody titre (p=<0.05). Vaccination with 100 μg and 150 μg of recombinant VP1 protein induced protective neutralizing antibody titers (>1.2) in guinea pigs compared to negative control (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: